Silver Book Fact

Following the current path, stroke cases will increase by 28.9% between 2003 and 2023 (estimates do not include strokes among the institutionalized population). If an alternative path is taken, there will be 18.8% (589,000) fewer stroke cases.

DeVol R, Bedroussian A, Charuworn A, Chatterjee A, et al. An Unhealthy America: The economic burden of chronic disease. The Milken Institute; 2007. https://assets1b.milkeninstitute.org/assets/Publication/ResearchReport/PDF/chronic_disease_report.pdf

Reference

Title
An Unhealthy America: The economic burden of chronic disease
Publisher
The Milken Institute
Publication Date
2007
Authors
DeVol R, Bedroussian A, Charuworn A, Chatterjee A, et al.
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • “Sherri Selph was 41 when she was first diagnosed with second-stage congestive heart failure. However, her rapidly diminishing health led to a diagnosis of end-stage heart disease. A heart transplant…  
  • Every additional dollar spent on antiplatelet therapy versus aspirin for the prevention of stroke in high-risk patients, has produced health gains valued between $2 and $6.  
  • Antihypertensive Medicines Have Prevented Deaths and Hospitalizations: Study quantified impact of high blood pressure drugs on the U.S. population 1999-2000  
  • Per-patient annual cost of treating stroke in atrial fibrillation patients
    The per-patient annual cost of treating stroke in atrial fibrillation patients was found to be $1,485 in a wellcontrolled anti-coagulation clinic, $3,710 for those receiving warfarin in routine medical care,…  
  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.